News on Carcinoma_Renal_Cell from BioPortfolio.com http://www.BioPortfolio.com Consolidated Carcinoma_Renal_Cell news from BioPortfolio.com Wed, 10 Feb 2010 00:53:50 GMT en NICE Consults On Preliminary Decision Not To Recommend Everolimus For Advanced Renal Cell Carcinomahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035572&HITNO=0&MSIZE=961&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carcinoma_Renal_Cell&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035572&THISHREF=http://c.moreover.com/click/here.pl%3fz2536276235%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035572&HITNO=0&MSIZE=961&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carcinoma_Renal_Cell&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035572&THISHREF=http://c.moreover.com/click/here.pl%3fz2536276235%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: Adipophilin expression in sebaceous tumors and other cutaneous lesions with clear cell histology: an immunohistochemical study of 117 caseshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034296&HITNO=1&MSIZE=961&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carcinoma_Renal_Cell&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034296&THISHREF=http://c.moreover.com/click/here.pl%3fz2535701065%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034296&HITNO=1&MSIZE=961&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carcinoma_Renal_Cell&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034296&THISHREF=http://c.moreover.com/click/here.pl%3fz2535701065%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: Medical News: NICE Consults On Preliminary Decision Not To Recommend Everolimus For Advanced Renal Cell Carcinomahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035532&HITNO=2&MSIZE=961&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carcinoma_Renal_Cell&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035532&THISHREF=http://c.moreover.com/click/here.pl%3fz2536270683%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035532&HITNO=2&MSIZE=961&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carcinoma_Renal_Cell&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035532&THISHREF=http://c.moreover.com/click/here.pl%3fz2536270683%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioFind: FDA Drug Approval Summary: Bevacizumab plus Interferon for Advanced Renal Cell Carcinomahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034220&HITNO=3&MSIZE=961&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carcinoma_Renal_Cell&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034220&THISHREF=http://c.moreover.com/click/here.pl%3fz2535682206%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034220&HITNO=3&MSIZE=961&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carcinoma_Renal_Cell&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034220&THISHREF=http://c.moreover.com/click/here.pl%3fz2535682206%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: NICE consults on preliminary decision not to recommend everolimus for advanced renal cell carcinomahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034210&HITNO=4&MSIZE=961&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carcinoma_Renal_Cell&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034210&THISHREF=http://c.moreover.com/click/here.pl%3fz2535680643%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034210&HITNO=4&MSIZE=961&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carcinoma_Renal_Cell&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034210&THISHREF=http://c.moreover.com/click/here.pl%3fz2535680643%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmiWeb: Kidney cancer drug rejected for being 'expensive'http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037276&HITNO=5&MSIZE=961&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carcinoma_Renal_Cell&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037276&THISHREF=http://c.moreover.com/click/here.pl%3fz2537008180%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037276&HITNO=5&MSIZE=961&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carcinoma_Renal_Cell&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037276&THISHREF=http://c.moreover.com/click/here.pl%3fz2537008180%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIn The News.co.uk: Drug for kidney cancer patients rejected on costhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034617&HITNO=6&MSIZE=961&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carcinoma_Renal_Cell&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034617&THISHREF=http://c.moreover.com/click/here.pl%3fz2535889282%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034617&HITNO=6&MSIZE=961&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carcinoma_Renal_Cell&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034617&THISHREF=http://c.moreover.com/click/here.pl%3fz2535889282%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYorkshire Post: Cancer drug rejected due to costhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032296&HITNO=7&MSIZE=961&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carcinoma_Renal_Cell&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032296&THISHREF=http://c.moreover.com/click/here.pl%3fz2534583727%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032296&HITNO=7&MSIZE=961&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carcinoma_Renal_Cell&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032296&THISHREF=http://c.moreover.com/click/here.pl%3fz2534583727%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! UK and Ireland: Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinomahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038678&HITNO=8&MSIZE=961&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carcinoma_Renal_Cell&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038678&THISHREF=http://c.moreover.com/click/here.pl%3fz2537703957%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038678&HITNO=8&MSIZE=961&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carcinoma_Renal_Cell&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038678&THISHREF=http://c.moreover.com/click/here.pl%3fz2537703957%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBritish Journal of Cancer: NICE warns industry on cost-effectivenesshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036369&HITNO=9&MSIZE=961&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carcinoma_Renal_Cell&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036369&THISHREF=http://c.moreover.com/click/here.pl%3fz2536587222%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036369&HITNO=9&MSIZE=961&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carcinoma_Renal_Cell&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036369&THISHREF=http://c.moreover.com/click/here.pl%3fz2536587222%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmafocus: Kidney cancer drug too expensive, says NICEhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034895&HITNO=10&MSIZE=961&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carcinoma_Renal_Cell&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034895&THISHREF=http://c.moreover.com/click/here.pl%3fz2536027696%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034895&HITNO=10&MSIZE=961&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carcinoma_Renal_Cell&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034895&THISHREF=http://c.moreover.com/click/here.pl%3fz2536027696%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNursing Times: Cancer drug fails recommendationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034654&HITNO=11&MSIZE=961&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carcinoma_Renal_Cell&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034654&THISHREF=http://c.moreover.com/click/here.pl%3fz2535911179%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034654&HITNO=11&MSIZE=961&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carcinoma_Renal_Cell&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034654&THISHREF=http://c.moreover.com/click/here.pl%3fz2535911179%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Europe: Questions remain on effectiveness of bariatric surgery in adolescentshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038137&HITNO=12&MSIZE=961&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carcinoma_Renal_Cell&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038137&THISHREF=http://c.moreover.com/click/here.pl%3fz2537496741%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038137&HITNO=12&MSIZE=961&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carcinoma_Renal_Cell&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038137&THISHREF=http://c.moreover.com/click/here.pl%3fz2537496741%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comUniversity of Texas: Equine Cancer: Squamous Cell Carcinomahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037976&HITNO=13&MSIZE=961&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carcinoma_Renal_Cell&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037976&THISHREF=http://c.moreover.com/click/here.pl%3fz2537409313%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037976&HITNO=13&MSIZE=961&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carcinoma_Renal_Cell&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037976&THISHREF=http://c.moreover.com/click/here.pl%3fz2537409313%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEquiSearch: Scottish cost regulators OKs Alimta and Stelara for NHS usehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034298&HITNO=14&MSIZE=961&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carcinoma_Renal_Cell&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034298&THISHREF=http://c.moreover.com/click/here.pl%3fz2535701605%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034298&HITNO=14&MSIZE=961&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carcinoma_Renal_Cell&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034298&THISHREF=http://c.moreover.com/click/here.pl%3fz2535701605%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Times: